SR618

Lower channel breakout bounce.

Pembelian
SR618 Diupdate   
NASDAQ:HRTX   Heron Therapeutics, Inc.
3
Low risk buy area. breaking out from lower regression channel w/divergence and volume. $15 will be some resistance, but after that could easily make it to $18.
Komentar:
finding resistance from the 20 and 50 ma. if can break that then this thing could get a decent pop.
Komentar:
seems that other sources say earnings are still in a week or so. so its looking good.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.